Innoviva, Inc. (INVA)
19.52
-0.13
(-0.66%)
USD |
NASDAQ |
Jan 09, 15:55
Innoviva Market Cap: 1.459B for Jan. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 175.55B |
| Eli Lilly & Co. | 953.37B |
| Merck & Co., Inc. | 274.49B |
| Pfizer Inc. | 144.90B |
| Keros Therapeutics, Inc. | 586.17M |
Market Cap Related Metrics
| PE Ratio | 14.00 |
| PS Ratio | 3.837 |
| PEG Ratio | 0.1364 |
| Price to Book Value | 1.445 |
| Price to Free Cash Flow | 7.854 |
| Price | 19.52 |
| Earnings Yield | 7.14% |
| PEGY Ratio | 0.1364 |
| Operating PE Ratio | 9.194 |
| Normalized PE Ratio | 11.33 |